VivaBioCell Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 3
Employees
  • Latest Deal Type
  • M&A

VivaBioCell General Information

Description

Provider of next-generation cell and tissue engineering therapies designed to regenerate and repair damaged tissues and organs. The company's cell and tissue engineering therapies can be used to develop immune cells utilized in the treatment of cancer such as natural killer cells enabling its clients to provide safe, efficacious, standardized and affordable medical treatments.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Parent Company
VBC Holdings
Primary Office
  • Via del Cotonificio, 127
  • 33100 Udine
  • Italy
+39 0432 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VivaBioCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Jun-2015 Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 Completed Startup
To view VivaBioCell’s complete valuation and funding history, request access »

VivaBioCell Executive Team (1)

Name Title Board Seat Contact Info
Francesco Curcio Chief Scientific Officer, President & Founder
To view VivaBioCell’s complete executive team members history, request access »

VivaBioCell Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial